Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard Piekarz, Robin Frye, Maria L. Turner, +17

Journal of Clinical Oncology

ImmunologyPathologyPharmacotherapyMetronomic ChemotherapyDermatology +16

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Richard Piekarz, Robin Frye, H. Miles Prince, +17

Blood

Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia

James L. Mulshine, Jane C. Atkinson, Robert O. Greer, +12

Clinical Cancer Research

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma

Susan E. Bates, Zhirong Zhan, Kenneth Steadman, +10

British Journal of Haematology

ImmunodeficienciesImmunologyPathologyPeripheral T‐cell LymphomaAbcb1 Gene Expression +15

Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

Sukyung Woo, Erin R. Gardner, Xiaohong Chen, +8

Clinical Cancer Research

Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers

Laleh Amiri‐Kordestani, Victoria Luchenko, Cody J. Peer, +12

Clinical Cancer Research

Romidepsin: A New Drug for the Treatment of Cutaneous T-Cell Lymphoma

Robin Frye, Mary Anne Myers, Karen C. Axelrod, +4

Clinical journal of oncology nursing

New DrugCutaneous T-cell LymphomaTranslational MedicineLymphoid NeoplasiaMedicine +13

Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL).

Richard Piekarz, Robin Frye, Steven L. Allen, +10

Blood

Low-dose electron beam radiation and romidepsin therapy for symptomatic cutaneous T-cell lymphoma lesions

Oleg E. Akilov, Clíona Grant, Robin Frye, +3

British Journal of Dermatology

Update of the NCI multiinstitutional phase II trial of romidepsin, FK228, for patients with cutaneous or peripheral T-cell lymphoma

Richard Piekarz, Robin Frye, John J. Wright, +8

Journal of Clinical Oncology

ImmunologyPathologyMetronomic ChemotherapyDermatologyImmunotherapy +15